The Netherlands
Triall, founded in 2018 and headquartered in The Netherlands, stands at the intersection of Health Care, Information Technology, and Life Sciences. Known for its slogan—"Building towards a future of smarter, safer, and more-efficient clinical trials."—the company is innovating the clinical trial landscape with its suite of SaaS and Web3 technologies.
Triall's offerings span the entire trial lifecycle, providing specialists with tools ranging from study design to post-study activities. A noteworthy upcoming feature, the Clinical Insights Exchange (CIX), promises data-driven insights for optimizing trial planning, leveraging privacy-enhancing technologies.
The firm also offers eClinical solutions tailored for various trial modalities—centralized, hybrid, and decentralized. Via strategic partnerships, Triall has cultivated a robust array of CRO services, ensuring comprehensive support in trial execution.
With a recent $2.40M Seed Round investment in July 2021, Triall appears well-poised to revolutionize clinical research through its innovative and extensive service capabilities.
